Antwerp, May 12, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its first quarter 2025 earnings prior to market opening on Thursday 21 May 2025 and will host a conference call at 8 …
JERUSALEM, ISRAEL, May 9, 2025 /EINPresswire.com/ -- French President Emmanuel Macron and EU High Representative Kaja Kallas address Israeli and Palestinian peacebuilders, with HRVP Kallas announcing €18m in new EU funding. On Friday, May 9, 2025, …
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 9, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings …
LONCIN, BELGIUM, May 8, 2025 /EINPresswire.com/ -- Ampacimon, a global leader in Dynamic Line Rating (DLR) technology, and Drone Volt, a key actor in professional civilian drones and an expert in on-board solutions, are thrilled to announce their …
Transparency Notification from Shareholders Ghent, Belgium – 8 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, …
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025 Mont-Saint-Guibert, Belgique – 7 mai 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie …
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 7 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical…
KYIV, UKRAINE, May 6, 2025 /EINPresswire.com/ -- Another stage of the screening of Ukrainian legislation for compliance with EU law has been completed in Brussels – this time covering Chapter 20, “Enterprise and Industrial Policy.” This is one of …
Antwerp, Belgium, May 6, 2025 – Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor of ALK5 (TGF-β …
CloudOffix to Exhibit at GITEX EUROPE 2025 in Berlin, Showcasing the Future of Total AI, Low-Code, and Total Experience CLAYMONT, DE, UNITED STATES, May 3, 2025 /EINPresswire.com/ -- CloudOffix, the world’s first and most comprehensive Low-Code …
CloudOffix Accelerates Global Expansion with New Strategic Partnerships in Europe and MENA CLAYMONT, DE, UNITED STATES, May 3, 2025 /EINPresswire.com/ -- CloudOffix, the pioneering low-code Total Experience Platform, announces plans to …
Sherrie Handrinos discusses how to earn media coverage and the key differences between earned PR and paid placement WASHINGTON, DC, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- In the debut edition of “Heard on the Streets,” a new series on …
As Europe seeks fresh innovation, Bright Labs 2025 emerges with a bold mission: to reignite the optimism, ambition, and ingenuity of a new founders' generation. ORADEA, ROMANIA, April 30, 2025 /EINPresswire.com/ -- At a time when …
KYIV, UKRAINE, April 30, 2025 /EINPresswire.com/ -- Ukraine and the United States of America have signed a Memorandum of Understanding to conclude an Agreement on Economic Partnership. The document confirms the parties’ readiness to cooperate on the …
Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – April 30, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its …
Antwerp, April 30, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) provides a business update following the recent announcements. The company held two Capital Markets Days together with Golden …
Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO New recruits expand senior team capabilities as the business progresses its lead HDAC6 inhibitor program, AGT-100216, into the clinic for the …
"FRAGMENTS OF FOLKLORE" A Landmark Exhibition Redefining Artistic Accessibility in Saudi Arabia RIYADH, SAUDI ARABIA, April 29, 2025 /EINPresswire.com/ -- Fragments of Folklore is a major exhibition that explores cultural identity …
Poster talk will present safety and efficacy data for ENaBL-T, a lentiviral vector for in vivo engineering of BCMA CAR T cells, which supported the first in vivo BCMA CAR-T cell therapy clinical trial for patients with relapse or refractory multiple …
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 28 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant …
